Hemangiopoietin, a novel human growth factor for the primitive cells of both hematopoietic and endothelial cell lineages

Blood

Volumn 103, Issue 12, 2004, Pages 4449-4456

  Liu, Yong Jun ^b   Lu, Shi Hong ^b   Xu, Bin ^b   Yang, Ren Chi ^b   Ren, Qian ^b   Liu, Bin ^b   Li, Bin ^b   Lu, Min ^b   Yan, Feng Ying ^b   Han, Zhi Bo ^b   Han, Zhong Chao ^a  

^a INSTITUTE OF HEMATOLOGY AND BLOOD DISEASES HOSPITAL   (China)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOPOIETIN; CD133 ANTIGEN; CD34 ANTIGEN; GROWTH FACTOR; HEMANGIOPOIETIN; KINASE DOMAIN RECEPTOR; PROTEIN; RECOMBINANT HUMAN HEMANGIOPOIETIN; STEM CELL ANTIGEN 1; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE MARROW CELL; CELL DIFFERENTIATION; CELL LINEAGE; CELL POPULATION; CELL PROLIFERATION; CONTROLLED STUDY; CYTOPENIA; ENDOTHELIUM CELL; GAMMA IRRADIATION; HAMANGIOBLAST; HEMATOPOIESIS; HEMATOPOIETIC CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MALE; MONONUCLEAR CELL; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RADIATION INJURY; RADIATION PROTECTION; STEM CELL; SURVIVAL RATE;

EID: 1642469279     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2003-06-1825     Document Type: Article

References (30)

1. Han ZC, Caen JP. Are megakaryocytes and endothelial cells sisters? J Lab Clin Med. 1993;121:821-825.
2. Bikfalvi A, Han ZC. Angiogenic factors are hematopoietic growth factors and vice versa. Leukemia. 1994;8:523-529.
3. Choi K, Kennedy M, Kazarov A, Papadimitriou JC, Keller G. A common precursor for hematopoietic and endothelial cells. Development. 1998;125:725-732.
4. Chung YS, Zhang WJ, Arentson E, Kingsley PD, Palis J, Choi K. Lineage analysis of the hemangioblast as defined by FLK1 and SCL expression. Development. 2002;129:5511-5520.
5. Ziegler BL, Valtieri M, Porada GA, et al. KDR receptor: a key marker defining hematopoietic stem cells. Science. 1999;285:1553-1558.
6. Shalaby F, Ho J, Stanford WL, et al. A requirement for flk-1 in primitive and definitive hematopoiesis and vasculogenesis. Cell. 1997;89:981-990.
7. Shalaby F, Rossant J, Yamaguchi TP, et al. Failure of blood-island formation and vasculogenesis in FLK-1 deficient mice. Nature. 1995;376:62-66.
8. Nishikawa SI, Nishikawa S, Hirashima M, Matsuyoshi N, Kodama H. Progressive lineage analysis by cell sorting and culture identifies FLK1 + VE-cadherin + cells at a diverging point of endothelial and hemopoietic lineages. Development. 1998;125:1747-1757.
9. Grant MB, May WS, Caballero S, et al. Adult hematopoietic stem cells provide functional hemangioblast activity during retinal neovascularization. Nat Med. 2002;8:607-612.
10. Pelosi E, Valtieri M, Coppola S, et al. Identification of the hemangioblast in postnatal life. Blood. 2002;100:3203-3208.
11. Peichev M, Naiyer AJ, Pereira D, et al. Expression of VEGFR-2 and AC133 by circulating human CD34+ cells identifies a population of functional endothetial precursors. Blood. 2000;95:952-958.
12. De Bont ES, Guikema JE, Scherpen F, et al. Mobilized human CD34+ hematopoietic stem cells enhance tumor growth in a nonobese diabetic/severe combined immunodeficient mouse model of human non-Hodgkin's lymphoma. Cancer Res. 2001;61:7654-7659.
13. Shi Q, Rafii S, Wu MH, et al. Evidence for circulating bone marrow-derived endothelial cells. Blood. 1998;92:362-367.
14. Gehling UM, Ergun S, Schumacher U, et al. In vitro differentiation of endothelial cells from AC133-positive progenitor cells. Blood. 2000;95:3106-3112.
15. Quirici N, Soligo D, Caneva L, Servida F, Bossolasco P, Deliliers GL. Differentiation and expansion of endothelial cells from human bone marrow CD133(+) cells. Br J Haematol. 2001;115:186-194.
16. Ribatti D, Vacca A, De Falco G, Ria R, Roncali L, Dammacco F. Role of hematopoietic growth factors in angiogenesis. Acta Haematol. 2001;106:157-161.
17. Jaquet K, Krause K, Tawakol-Khodai M, Geidel S, Kuck KH. Erythropoietin and VEGF exhibit equal angiogenic potential. Microvasc Res. 2002;64:326-333.
18. Han ZC, Lu M, Xi XD, et al. Platelet factor 4 and other CXC chemokines support the survival of normal hematopoietic cells and reduce the chemosensitivity of cells to cytotoxic agents. Blood. 1997;89:2328-2335.
19. Aidoudi S, Guigon M, Lebeurier I, Caen JP, Han ZC. In vivo effect of platelet factor 4 (PF4) and tetrapeptide AcSDKP on hematopoiesis of mice treated by 5-fluorouracil. Br J Haematol. 1996;94:443-448.
20. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 1987;162:156-159.
21. Rizzo S, Scopes J, Elebute MO, Papadaki HA, Gordon-Smith EC, Gibson FM. Stem cell defect in aplastic anemia: reduced long term culture-initiating cells (LTC-IC) in CD34+ cells isolated from aplastic anemia patient bone marrow. Hematol J. 2002;3:230-236.
22. Leary AG, Yang YC, Clark SC, Golde DW, Ogawa M. Recombinant gibbon interleukin-3 supports formation of human multilineage colonies and blast cell colonies culture: comparison with recombinant human granulocyte-macrophage colony-stimulating factor. Blood 1987;70:1343-1348.
23. Ikegawa S, Sano M, Koshizuka Y, Nakamura Y. Isolation, characterization and mapping of the mouse and human PRG4 (proteoglycan 4) genes. Cytogenet Cell Genet. 2000;90:291-297.
24. Flannery CR, Hughes CE, Schumacher BL, et al. Articular cartilage superficial zone protein (SZP) is homologous to megakaryocyte stimulating factor precursor and is a multifunctional proteoglycan with potential growth-promoting, cytoprotective, and lubricating properties in cartilage metabolism. Biochem Biophys Res Commun. 1999;254:535-541.
25. Turner KJ, Fitz LJ, Temple P, et al. Purification, biochemical characterization, and cloning of a novel megakaryocyte stimulating factor that has megakaryocyte colony stimulating activity [abstract]. Blood. 1991;78:279a.
26. Lebeurier I, Basara N, Aidoudi S, Amiral J, Caen JP, Han ZC. Carboxy-terminal peptides (C1-24 and C13-24 but not C1-13) of platelet factor 4 inhibit murine megakaryocytopoiesis, an activity which is neutralized by heparin. Br J Haematol. 1996;92:29-34.
27. Maciejewski JP, Risitano A, Kook H, Zeng W, Chen G, Young NS. Immune pathophysiology of aplastic anemia. Int J Hematol. 2002;76(suppl 1):207-214.
28. Zsebo KM, Smith KA, Hartley CA, et al. Radioprotection of mice by recombinant rat stem cell factor. Proc Natl Acad Sci U S A. 1992;89:9464-9468.
29. Gratwohl A, John L, Baldomero H, et al. FLT-3 ligand provides hematopoietic protection from total body irradiation in rabbits. Blood. 1998;92:765-769.
30. Mouthon MA, Van der Meeren A, Gaugler MH, et al. Thrombopoietin promotes hematopoietic recovery and survival after high-dose whole body irradiation. Int J Radiat Oncol Biol Phys. 1999;43:867-875.